Black Titan Corp (NASDAQ:BTTC) Shares Shorted: Short Interest Down 51.6% in September

Black Titan Corp (NASDAQ:BTTC) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totaling 10,495 shares, a decrease of 51.6% from the August 31st total of 21,671 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average trading volume of 108,286 shares, the days-to-cover ratio is presently 0.1 days.

Black Titan Trading Up 17.5%

Shares of BTTC stock opened at $0.61 on Thursday. The business has a 50-day moving average price of $0.57 and a two-hundred day moving average price of $0.92. Black Titan has a 12-month low of $0.34 and a 12-month high of $39.00. The company has a quick ratio of 4.62, a current ratio of 4.62 and a debt-to-equity ratio of 0.06. The firm has a market cap of $6.58 million, a P/E ratio of -0.21 and a beta of 1.17.

Black Titan Company Profile

Titan Pharmaceuticals, Inc is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.